Caris Life Sciences (CAI) Receivables - Net (2024 - 2026)

Caris Life Sciences' Receivables - Net history runs 3 years deep, the most recent figure standing at $90.5 million for Q1 2026.

• In Q1 2026, Receivables - Net changed N/A year-over-year to $90.5 million; the TTM figure through Mar 2026 stood at $90.5 million (changed N/A YoY), while the FY2025 annual figure was $112.1 million, up 27.08% from the prior year.
• Receivables - Net was $90.5 million for Q1 2026 at Caris Life Sciences, down from $112.1 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $112.1 million in Q4 2025 to a low of $26.7 million in Q3 2025.
• Historically, Receivables - Net has averaged $73.7 million across 3 years, with a median of $88.2 million in 2024.
• Biggest YoY gain for Receivables - Net was 27.08% in 2025; the steepest drop was 27.08% in 2025.
• A 3-year view of Receivables - Net shows it stood at $88.2 million in 2024, then increased by 27.08% to $112.1 million in 2025, then dropped by 19.28% to $90.5 million in 2026.
• The last three Receivables - Net figures came in at $90.5 million (Q1 2026), $112.1 million (Q4 2025), and $26.7 million (Q3 2025), per Business Quant data.